Cited by 516Chronic Obstructive Pulmonary Disease (COPD) ResearchMedication Adherence and ComplianceInhalation and Respiratory Drug Delivery

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Adherence to inhaled therapy, mortality and hospital admission in COPD

Open access

Vestbo, J, Anderson, J A, Calverley, P M A, Celli, B, Ferguson, G T, Jenkins, C, Knobil, K, Willits, L R, Yates, J C, Jones, P W·2009·Thorax

DOI 10.1136/thx.2009.113662

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Little is known about adherence to inhaled medication in chronic obstructive pulmonary disease (COPD) and the impact on mortality and morbidity. METHODS: Data on drug adherence from a randomised double-blind trial comparing inhaled salmeterol 50 microg + fluticasone propionate 500 microg twice daily with placebo and each drug individually in 6112 patients with moderate to severe COPD over 3 years in the TORCH study were used. All-cause mortality and exacerbations leading to hospital admission were primary and secondary end points. The study of adherence was not specified a priori as an ancillary study. RESULTS: Of the 4880 patients (79.8%) with good adherence defined as >80% use of study medication, 11.3% died compared with 26.4% of the 1232 patients (20.2%) with poor adherence. The annual rates of hospital admission for exacerbations were 0.15 and 0.27, respectively. The association between adherence and mortality remained unchanged and statistically significant after adjusting for other factors related to prognosis (hazard ratio 0.40 (95% CI 0.35 to 0.46), p<0.001). The association was even stronger when analysing on-treatment deaths only. Similarly, the association between adherence and hospital admission remained unchanged and significant in a multivariate analysis (rate ratio 0.58 (95% CI 0.44 to 0.73, p<0.001). The association between increased adherence and improved mortality and reduction in hospital admission was independent of study treatment. The effect of treatment was more pronounced in patients with good adherence than in those with poor adherence. CONCLUSION: Adherence to inhaled medication is significantly associated with reduced risk of death and admission to hospital due to exacerbations in COPD. Further research is needed to understand these strong associations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/thx.2009.113662

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citation
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Self-citation
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Self-citation
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
Rodríguez, R. (2007) · Cited by 1,412
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353 · cited 3×
“treatment with a drug with positive effects to that in patients receiving placebo.(1) Most of the studies”
BackgroundMethodResultInfluential
Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study
Garcia-Aymerich, J., Lange, P., Benet, M., Schnohr, P., & Anto, J. M. (2006) · Thorax · doi:10.1136/thx.2006.060145 · Cited by 1,113
Mortality in COPD: role of comorbidities
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052
Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease A Disease-Specific Self-management Intervention
Bourbeau, J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.5.585 · Cited by 933
The Handbook of health behavior change
(2009) · Choice Reviews Online · doi:10.5860/choice.46-6233 · Cited by 616
Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care
Soriano, J. B., Visick, G. T., Muellerova, H., Payvandi, N., & Hansell, A. L. (2005) · Chest · doi:10.1378/chest.128.4.2099 · Cited by 615

Flagged first, then by citations

Show all 32 references

Sorted by citations

Items 101–200 of 514

The Special Challenge of Nonadherence With Sublingual Immunotherapy
Bender, B. G., & Oppenheimer, J. J. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.01.003 · Cited by 45
Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy
van Boven, J. F. M., Lavorini, F., Dekhuijzen, P. N. R., Blasi, F., Price, D. B., & Viegi, G. (2017) · European Respiratory Journal · doi:10.1183/13993003.00076-2017 · Cited by 43
The Importance of Inhaler Adherence to Prevent COPD Exacerbations
Jardim, J. R., & Nascimento, O. A. (2019) · Medical Sciences · doi:10.3390/medsci7040054 · Cited by 43
Adherence to inhalers and comorbidities in COPD patients. A cross-sectional primary care study from Greece
Ierodiakonou, D., Sifaki-Pistolla, D. I., Kampouraki, M., Poulorinakis, I., Papadokostakis, P., Gialamas, I., Athanasiou, P., Bempi, V., Lampraki, I., Tsiligianni, I., et al. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01296-3 · Cited by 43
Adherence to Inhaled Medications and its Effect on Healthcare Utilization and Costs Among High-Grade Chronic Obstructive Pulmonary Disease Patients
Kim, J.-A., Lim, M. K., Kim, K.-I., Park, J., & Rhee, C. K. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0612-2 · Cited by 42
A Systematic Review of the Efficacy and Safety of a Fixed-Dose Combination of Umeclidinium and Vilanterol for the Treatment of COPD
Rodrigo, G. J., & Neffen, H. E. (2015) · CHEST Journal · doi:10.1378/chest.15-0084 · Cited by 41
Using Video Telehealth to Facilitate Inhaler Training in Rural Patients with Obstructive Lung Disease
Locke, E. R., Thomas, R. M., Woo, D. M., Nguyen, E. H. K., Tamanaha, B. K., Press, V. G., Reiber, G. E., Kaboli, P. J., & Fan, V. S. (2018) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2017.0330 · Cited by 41
The INCATM (Inhaler Compliance AssessmentTM): A comparison with established measures of adherence
Moran, C. N., Doyle, F., Sulaiman, I., Bennett, K., Greene, G., Molloy, G. J., Reilly, R. B., Costello, R. W., & Mellon, L. (2017) · Psychology and Health · doi:10.1080/08870446.2017.1290243 · Cited by 41
Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk
Covelli, H. D., Pek, B., Schenkenberger, I., Scott-Wilson, C. A., Emmett, A. H., & Crim, C. C. (2015) · International Journal of COPD · doi:10.2147/copd.s91407 · Cited by 40
Switching treatments in COPD: implications for costs and treatment adherence
Braido, F., Lavorini, F., Blasi, F., Baiardini, I., & Canonica, G. W. (2015) · International Journal of COPD · doi:10.2147/copd.s79635 · Cited by 39
Medication availability and economic barriers to adherence in asthma and COPD patients in low-resource settings
Tabyshova, A. K., Sooronbaev, T., Akylbekov, A., Mademilov, M., Isakova, A., Erkinbaeva, A., Magdieva, K., Chavannes, N. H., Postma, M. J., & van Boven, J. F. M. (2022) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-022-00281-z · Cited by 39
Study of potentially preventable hospitalisations (PPH) for chronic conditions: what proportion are preventable and what factors are associated with preventable PPH?
Johnston, J. J., Longman, J. M., Ewald, D. P., King, J., Das, S. K., & Passey, M. E. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038415 · Cited by 38
A review of the value of innovation in inhalers for COPD and asthma
Virchow, J. C., Jr., Akdiş, C. A., Darbà, J., Dekhuijzen, R. P. N., Hartl, S., Kobelt, G., Roger, A., Simoens, S., Toumi, M., Woodhouse, B., et al. (2015) · Journal of Market Access & Health Policy · doi:10.3402/jmahp.v3.28760 · Cited by 37
Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD
Cazzola, M., Beeh, K. M., Price, D. B., & Roche, N. (2015) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2015.02.007 · Cited by 37
The use of nebulized pharmacotherapies during the COVID-19 pandemic
Sethi, S., Barjaktarević, I., & Tashkin, D. P. (2020) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620954366 · Cited by 37
Treatment Adherence in Patients with Obstructive Pulmonary Diseases
Homętowska, H., Świątoniowska-Lonc, N., Klekowski, J., Chabowski, M., & Jankowska‐Polańska, B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811573 · Cited by 37
Personalising adherence-enhancing interventions using a smart inhaler in patients with COPD: an exploratory cost-effectiveness analysis
van Boven, J. F. M., Cushen, B., Sulaiman, I., Greene, G., MacHale, E., Mokoka, M., Doyle, F., Reilly, R. B., Bennett, K., & Costello, R. W. (2018) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-018-0092-8 · Cited by 36
Factors Influencing Adherence to Treatment in COPD Patients and Its Relationship with Disease Exacerbations
Wiśniewski, D., Porzezińska, M., Gruchała‐Niedoszytko, M., Niedoszytko, M., Słomiński, J. M., & Jassem, E. (2014) · Advances in respiratory medicine · doi:10.5603/piap.2014.0015 · Cited by 36
The impact of adherence to inhaled drugs on 5‐year survival in COPD patients: a time dependent approach
Belleudi, V., Martino, M. D., Cascini, S., Kirchmayer, U., Pistelli, R., Formoso, G., Fusco, D., Davoli, M., Agabiti, N., & on behalf of the OUTPUL Study Group (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4059 · Cited by 35
Adherence to Global Initiative for Chronic Obstructive Lung Disease guidelines in the real world: current understanding, barriers, and solutions
Albitar, H. A. H., & Iyer, V. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000655 · Cited by 34
Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition
Ingebrigtsen, T. S., Marott, J. L., Lange, P., Hallas, J., Nordestgaard, B. G., & Vestbo, J. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.10.015 · Cited by 33
Self-citation
COPD: Analysing factors associated with a successful treatment
Duarte-de-Araújo, A., Teixeira, P., Hespanhol, V. P., & Correia-de-Sousa, J. (2019) · Pulmonology · doi:10.1016/j.pulmoe.2019.05.012 · Cited by 33
A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future
de Llano, L. P., Miravitlles, M., Golpe, R., Gutiérrez, F. J. Á., Cisneros, C., Almonacid, C., Martínez‐Moragón, E., González‐Barcala, F. J., Ramos‐Barbón, D., Plaza, V., et al. (2020) · International Journal of COPD · doi:10.2147/copd.s263430 · Cited by 35
Impact of pharmaceutical care in the improvement of medication adherence and quality of life for COPD patients in Vietnam
Nguyen, T.-S., Nguyen, T. L. H., Pham, T. T. V., Hua, S., Chau, N. Q., & Li, S. C. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.05.006 · Cited by 32
Association Between Adherence to Maintenance Medication in Patients with COPD and Acute Exacerbation Occurrence and Cost in China: A Retrospective Cohort Database Study
Chen, R., Gao, Y., Wang, H., Shang, H., & Xuan, J. (2020) · International Journal of COPD · doi:10.2147/copd.s234349 · Cited by 33
Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPD
Mahler, D. A., & Halpin, D. M. G. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.03.049 · Cited by 32
Provider Views About Responsibility for Medication Adherence and Content of Physician–Older Patient Discussions
Tarn, D. M., Mattimore, T. J., Bell, D. S., Kravitz, R. L., & Wenger, N. S. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03969.x · Cited by 33
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
Arievich, H., Overend, T., Renard, D., Gibbs, M., Alagappan, V., Looby, M., & Banerji, D. D. (2012) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-12-74 · Cited by 32
Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data
Tueller, S., Deboeck, P. R., & Dorn, R. A. V. (2016) · Journal of Behavioral Medicine · doi:10.1007/s10865-016-9727-9 · Cited by 36
Optimising pharmacological maintenance treatment for COPD in primary care
Jones, R. C. M., & Østrem, A. (2010) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2010.00069 · Cited by 31
Indacaterol for chronic obstructive pulmonary disease (COPD)
Cazzola, M., Proietto, A., & Matera, M. G. (2010) · Drugs of today · doi:10.1358/dot.2010.46.3.1450070 · Cited by 31
Effect of an integrated care programme on re‐hospitalization of patients with chronic obstructive pulmonary disease
Moullec, G., Lavoie, K., Rabhi, K., Julien, M., (c), H. F., & Labrecque, M. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02168.x · Cited by 31
El test de adhesión a los inhaladores
Plaza, V., López-Viña, A., & Cosío, B. G. (2016) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2016.08.006 · Cited by 31
A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
Fenker, D. E., McDaniel, C. T., Panmanee, W., Panos, R. J., Sorscher, E. J., Sabusap, C. M. P., Clancy, J. P., & Hassett, D. J. (2018) · International Journal of Respiratory and Pulmonary Medicine · doi:10.23937/2378-3516/1410098 · Cited by 32
Electronic inhaler monitoring and healthcare utilization in chronic obstructive pulmonary disease
Alshabani, K., Attaway, A. H., Smith, M. J., Majumdar, U., Rice, R., Han, X., Wang, X., & Hatipoglu, U. S. (2019) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x19850404 · Cited by 31
Association of Medication Adherence and Clinical Outcomes in Sarcoidosis
Sharp, M., Brown, T., Chen, E. S., Rand, C. S., Möller, D. R., & Eakin, M. N. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.01.026 · Cited by 32
Emerging Technologies for Electronic Monitoring of Adherence, Inhaler Competence, and True Adherence
Pritchard, J. N., & Nicholls, C. (2014) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2014.1163 · Cited by 31
Identifying poor compliance with CPAP in obstructive sleep apnoea: A simple prediction equation using data after a two week trial
Ghosh, D., Allgar, V. L., & Elliott, M. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.10.008 · Cited by 31
The influence of type of inhalation device on adherence of COPD patients to inhaled medication
Huurne, K. K.-T., Movig, K. L. L., van der Valk, P., van der Palen, J. A. M., & Brusse-Keizer, M. G. J. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1130695 · Cited by 30
Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
Dransfield, M. T., Feldman, G., Korenblat, P. E., LaForce, C., Locantore, N., Pistolesi, M., Watkins, M. L., Crim, C. C., & Martínez, F. J. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.05.008 · Cited by 30
Survival in COPD
Miniati, M., Monti, S., Pavlickova, I., & Bottai, M. (2014) · Medicine · doi:10.1097/md.0000000000000076 · Cited by 30
Chronic obstructive pulmonary disease phenotypes using cluster analysis of electronic medical records
Vazquez Guillamet, R., Ursu, O., Iwamoto, G., Moseley, P. L., & Oprea, T. (2018) · Health Informatics Journal · doi:10.1177/1460458216675661 · Cited by 30
The pharmacy care plan service: Evaluation and estimate of cost-effectiveness
Twigg, M. J., Wright, D. J., Barton, G., Kirkdale, C. L., & Thornley, T. (2018) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2018.03.062 · Cited by 31
Giving Voice to the Medically Under-Served: A Qualitative Co-Production Approach to Explore Patient Medicine Experiences and Improve Services to Marginalized Communities
Latif, A., Tariq, S., Abbasi, N., & Mandane, B. (2018) · Pharmacy · doi:10.3390/pharmacy6010013 · Cited by 30
Adherence to treatment guidelines and long‐term survival in hospitalized patients with chronic obstructive pulmonary disease
Šarc, I., Jeric, T., Ziherl, K., Šuškovič, S., Košnik, M., Anker, S. D., & Lainščak, M. (2011) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2010.01617.x · Cited by 29
Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease
Rodriguez‐Roisin, R., Tetzlaff, K., Watz, H., Wouters, E. F. �., Disse, B. G., Finnigan, H., MAGNUSSEN, H., & Calverley, P. M. A. (2016) · International Journal of COPD · doi:10.2147/copd.s106142 · Cited by 29
Self-citation
Adherence to Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review
Świątoniowska-Lonc, N., Chabowski, M., Polański, J., Mazur, G. J., & Jankowska‐Polańska, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_477 · Cited by 29
Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation
Mannino, D. M., Bogart, M., Germain, G., Huang, S. P., Ismaila, A., Laliberté, F., Jung, Y. Y., MacKnight, S. D., Stiegler, M. P., & Duh, M. S. (2022) · International Journal of COPD · doi:10.2147/copd.s337668 · Cited by 29
Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients
Takemura, Mitsui, Ido, Matsumoto, M., Koyama, Inoue, Takamatsu, Itotani, Ishitoko, Сузуки, et al. (2013) · International Journal of COPD · doi:10.2147/copd.s44022 · Cited by 33
Doctor-patient relationship: a resource to improve respiratory diseases management.
Santus, P., Picciolo, S., Proietto, A., Falcone, F., Mangiacavallo, A., Pellegrino, G., Sereno, F., Radovanovic, D., Blasi, F., Girbino, G., et al. (2012) · European journal of internal medicine · doi:10.1016/j.ejim.2012.04.004 · Cited by 29
Pharmacological Therapy of COPD
Celli, B. R. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.07.005 · Cited by 28
Self-citation
Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Industrial Regions of China: A Multicenter Cross-Sectional Study
Dong, H., Hao, Y., Li, D., Su, Z., Li, W., Shi, B., & Gao, P. (2020) · International Journal of COPD · doi:10.2147/copd.s270729 · Cited by 28
Factors associated with self‐management behaviors of patients with chronic obstructive pulmonary disease
Lan, X., Lu, X., Yi, B., Chen, X., & Jin, S. (2021) · Japan Journal of Nursing Science · doi:10.1111/jjns.12450 · Cited by 29
Chronic Obstructive Pulmonary Disease Exacerbations: A Need for Action
Anzueto, A., & Miravitlles, M. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.05.003 · Cited by 28
COPD: Providing the right treatment for the right patient at the right time
Agustí, A. G. N., Ambrosino, N., Blackstock, F. C., Bourbeau, J., Casaburi, R. H., Celli, B. R., Criner, G. J., Crouch, R. H., Negro, R. W. D., Dreher, M., et al. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.107041 · Cited by 32
Self-citation
Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM Workshop
Roche, N., Scheuch, G., Pritchard, J. N., Nopitsch-Mai, C., Lakhani, D. A., Saluja, B., Jamieson, J., Dundon, A., Wallace, R., Holmes, S., et al. (2016) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2016.1326 · Cited by 28
Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India
Abdulsalim, S., Unnikrishnan, M. K., Manu, M. K., Alsahali, S. M., Alrasheedy, A. A., Martin, A. P., Godman, B., & Alfadl, A. A. (2019) · PharmacoEconomics - Open · doi:10.1007/s41669-019-0172-x · Cited by 27
Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD
Miravitlles, M., Marín, A., Huerta, A., Carcedo, D., Villacampa, A., & Puig‐Junoy, J. (2020) · International Journal of COPD · doi:10.2147/copd.s253567 · Cited by 27
Half a Century of Technological Advances in Pulmonary Drug Delivery: A Personal Perspective
Clark, A. R. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.871147 · Cited by 27
Maintaining Control of Chronic Obstructive Airway Disease: Adherence to Inhaled Therapy and Risks and Benefits of Switching Devices
Melani, A. S., & Paleari, D. (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1045972 · Cited by 27
Adherence and healthcare utilization among older adults with COPD and depression
Albrecht, J. S., Khokhar, B., Huang, T.-Y., Wei, Y. J., Harris, I., Moyo, P., Hur, P., Lehmann, S. W., Netzer, G., & Simoni, J. M. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.06.002 · Cited by 27
Lay Health Coaching to Increase Appropriate Inhaler Use in COPD: A Randomized Controlled Trial
Willard‐Grace, R., Chirinos, C., Wolf, J. S., DeVore, D., Huang, B., Hessler, D., Tsao, S., Su, G., & Thom, D. H. (2020) · The Annals of Family Medicine · doi:10.1370/afm.2461 · Cited by 26
Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus
Rio, F. G., Soler‐Cataluña, J. J., Navarrete, B. A., Viejo, J. L., & Miravitlles, M. (2017) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2017.1365120 · Cited by 26
Investigating the Accuracy of the Digihaler, a New Electronic Multidose Dry-Powder Inhaler, in Measuring Inhalation Parameters
Chrystyn, H., Saralaya, D., Shenoy, A., Toor, S., Kastango, K. B., Calderon, E., Li, T. Y., & SAFIOTI, G. G. (2021) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2021.0031 · Cited by 28
Adherence to inhaled therapy in COPD: effects on survival and exacerbations
Antoniu, S. A. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.10 · Cited by 26
Assessment of Poor Inhaler Technique in Older Patients with Asthma or COPD: A Predictive Tool for Clinical Risk and Inhaler Performance
Maricoto, T., Santos, D., Carvalho, C., Teles, I., Correia-de-Sousa, J., & Taborda‐Barata, L. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00779-6 · Cited by 26
Differences in Adherence to Common Inhaled Medications in COPD
Huurne, K. K.-T., Movig, K. L. L., van der Valk, P., van der Palen, J. A. M., & Brusse-Keizer, M. G. J. (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.995292 · Cited by 25
Measuring adherence to therapy in airways disease
Holmes, J., & Heaney, L. G. (2021) · Breathe · doi:10.1183/20734735.0037-2021 · Cited by 29
Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey
Braido, F., Baiardini, I., Sumberesi, M., Blasi, F., & Canonica, G. W. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-94 · Cited by 25
Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey
Hollingworth, K., Müllerová, H., Landis, S., Айсанов, З. Р., Davis, K. J., Ichinose, M., Mannino, D. M., Maskell, J., Menezes, A. M. B., van der Molen, T., et al. (2016) · International Journal of COPD · doi:10.2147/copd.s102280 · Cited by 26
Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis
White, H., Shaw, N., Denman, S., Pollard, K., Wynne, S., & Peckham, D. G. (2017) · European Respiratory Journal · doi:10.1183/13993003.00987-2016 · Cited by 25
Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group—European Academy of Allergy and Clinical Immunology Task Force
Roche, N., Campbell, J. D., Krishnan, J. A., Brusselle, G., Chisholm, A., Bjermer, L. H., Thomas, M. D., Ganse, E. H. V., van den Berge, M., Christoff, G., et al. (2019) · Clinical and Translational Allergy · doi:10.1186/s13601-019-0255-x · Cited by 25
Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD
Huurne, K. K.-T., Groothuis‐Oudshoorn, C. G. M., VanderValk, P. D. L. P. M., Movig, K. L. L., van der Palen, J. A. M., & Brusse-Keizer, M. G. J. (2018) · International Journal of COPD · doi:10.2147/copd.s161374 · Cited by 24
A quantitative evaluation of adherence and inhalation technique among respiratory patients: An observational study using an electronic inhaler assessment device
Hesso, I., Nabhani‐Gebara, S., Greene, G., stello, R. W. C., & Kayyali, R. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13437 · Cited by 24
Association between medication adherence and health-related quality of life in patients with chronic obstructive pulmonary disease
Moradkhani, B., Mollazadeh, S., Niloofar, P., Bashiri, A., & Oghazian, M. B. (2021) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-021-00222-x · Cited by 28
Effectiveness of individualized inhaler technique training on low adherence (LowAd) in ambulatory patients with COPD and asthma
Sánchez-Nieto, J. M., Bernabéu-Mora, R., Fernández-Muñoz, I., Carrillo‐Alcaraz, A., Fructuoso, J. A., Fernández-Alvarez, J., Olmos, J. C. V., Martínez-Ferre, M. J., Olea, M. G.-V., Valenciano, M. J. C., et al. (2022) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-021-00262-8 · Cited by 27
Cost-Effectiveness and Impact on Health Care Utilization of Interventions to Improve Medication Adherence and Outcomes in Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review
van Boven, J. F. M., Lavorini, F., Ágh, T., Sadatsafavi, M., Patino, O., & Muresan, B. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.12.049 · Cited by 24
The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: A longitudinal cohort study
Wei, Y. J., Simoni‐Wastila, L., Albrecht, J. S., HUANG, T.-Y. J., Moyo, P., Khokhar, B., Harris, I., LANGENBERG, P. W., Netzer, G., & Lehmann, S. W. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4772 · Cited by 26
Optimal cut-off value and clinical usefulness of the Adherence Starts with Knowledge-12 in patients with asthma taking inhaled corticosteroids
Takemura, M., Nishio, M., Fukumitsu, K., Takeda, N., Ichikawa, H., Asano, T., Tomita, H., Kanemitsu, Y., Yoshikawa, K., & Niimi, A. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.06.115 · Cited by 24
Executive Agency for Health and Consumers
Looper, L. (2014) · European Union regulations | European Encyclopedia of law · Cited by 24
Long-acting ß-adrenoceptor agonists in the management of COPD: focus on indacaterol
Beeh, K. M. (2011) · International Journal of COPD · doi:10.2147/copd.s7371 · Cited by 23
Indacaterol for Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis
Chung, V. C., Ma, H., Hui, D. S. C., Tam, W., & Tang, J. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070784 · Cited by 23
A qualitative study exploring the lived experience of medication use in different disease states: Linking experiences of disease symptoms to medication adherence
Rathbone, A. P., Jamie, K., Todd, A., & Husband, A. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13288 · Cited by 26
Differences Between Men and Women with Chronic Obstructive Pulmonary Disease
Jenkins, C. R. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2021.06.001 · Cited by 34
Self-citation
Treatment of COPD: from pharmacological to instrumental therapies
Alifano, M., Cuvelier, A., Delage, A., Roche, N., Lamia, B., Molano, L. C., Couderc, L.-J., Marquette, C., & Devillier, P. (2010) · European Respiratory Review · doi:10.1183/09059180.00008009 · Cited by 24
Effects of targeting disease and medication management interventions towards patients with COPD
van Boven, J. F. M., Stuurman-Bieze, A. G. G., Hiddink, E., & Postma, M. J. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1110129 · Cited by 24
Medication adherence to inhalation therapy and the risk of COPD exacerbations: a systematic review with meta-analysis
Vauterin, D., Vaerenbergh, F. V., Grymonprez, M., Vanoverschelde, A., & Lahousse, L. (2024) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-001964 · Cited by 35
A non-randomised controlled pilot study of clinical pharmacist collaborative intervention for community dwelling patients with COPD
Hunt, V., Anderson, D., Lowrie, R., Sardar, C. M., Ballantyne, S., Bryson, G., Kyle, J., & Hanlon, P. (2018) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-018-0105-7 · Cited by 22
Evidence of the association between adherence to treatment and mortality among patients with COPD monitored at a public disease management program in Brazil
de Moreira, A. T. A., Pinto, C. R., Lemos, A. C. M., Costa, L. A., Souza, G. S., & Netto, E. M. (2022) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20210120 · Cited by 22
Smart dry powder inhalers and intelligent adherence management
Häußermann, S., Arendsen, L. J., & Pritchard, J. N. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114580 · Cited by 23
Patient Education and Adherence to Aerosol Therapy
Ari, A. (2015) · Respiratory Care · doi:10.4187/respcare.03854 · Cited by 22
Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
Kort, S., Huurne, K. K.-T., van der Palen, J. A. M., van Beurden, W., Movig, K. L. L., van der Valk, P., & Brusse-Keizer, M. G. J. (2016) · International Journal of COPD · doi:10.2147/copd.s107303 · Cited by 23
The Association Between Technology Use and Health Status in a Chronic Obstructive Pulmonary Disease Cohort: Multi-Method Study
Witry, M. J., Comellas, A. P., Simmering, J. E., & Polgreen, P. M. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9382 · Cited by 22
Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study
Bogart, M., Stanford, R. H., Reinsch, T. K., HULL, M. L., Buikema, A. R., & Hulbert, E. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.07.009 · Cited by 22
Medication adherence halves COPD patients’ hospitalization risk – evidence from Swiss health insurance data
Bischof, A. Y., Cordier, J., Vogel, J., & Geißler, A. (2024) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-024-00361-2 · Cited by 21
Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study
Moretz, C., Sharpsten, L., Bengtson, L. G. S., Koep, E., Le, L. B., Tong, J., Stanford, R. H., Hahn, B. A., & Ray, R. (2019) · International Journal of COPD · doi:10.2147/copd.s204649 · Cited by 21
Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial
Davis, E., Marra, C. A., Gamble, J., Farrell, J., Lockyer, J., FitzGerald, J. M., Abu-Ashour, W., Gillis, C. J., & Hawboldt, J. (2016) · Trials · doi:10.1186/s13063-016-1623-7 · Cited by 23
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD
Donner, C. F., Amaducci, S., Bacci, E., Baldacci, S., Bartoli, M. L., Beghi, G. M., Benfante, A., Brighindi, S., Casali, L., Castiglia, D., et al. (2018) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2018.886 · Cited by 21
Breathing Out Completely Before Inhalation: The Most Problematic Step in Application Technique in Patients With Non-Mild Chronic Obstructive Pulmonary Disease
Vytrisalova, M., Hendrychova, T., Touskova, T. P., Zimčíková, E., Vlček, J., Nevoránek, L., Svoboda, M., Hejduk, K., Brat, K., Plutinský, M., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00241 · Cited by 21
COPD Management in Community Pharmacy Results in Improved Inhaler Use, Immunization Rate, COPD Action Plan Ownership, COPD Knowledge, and Reductions in Exacerbation Rates
Fathima, M., Bawa, Z., Mitchell, B., Foster, J. M., Armour, C. L., & Saini, B. (2021) · International Journal of COPD · doi:10.2147/copd.s288792 · Cited by 21

Authors: Vestbo, J., Anderson, J. A., Calverley, P. M. A., Celli, B., Ferguson, G. T., Jenkins, C., Knobil, K., Willits, L. R., Yates, J. C., & Jones, P. W.
Affiliations: University of Manchester (GB)
GlaxoSmithKline (United Kingdom) (GB)
Aintree University Hospital (GB)
Tufts University (US)
Woolcock Institute of Medical Research (AU)
GlaxoSmithKline (United States) (US)
St George's, University of London (GB)
Corresponding author: Vestbo, J
ORCID: Vestbo, J
Anderson, J A
Calverley, P M A
Celli, B
Ferguson, G T
Jenkins, C
Yates, J C
Jones, P W
Venue: Thorax
Publisher: BMJ
Published: 2009-08-23
Volume: 64
Issue: 11
Pages: 939-943
ISSN: 0040-6376 (ISSN-L)
DOI: 10.1136/thx.2009.113662
OpenAlex: W2095666112
Cited by: 516
References: 32
Citations by year: 2026: 17 · 2025: 22 · 2024: 36 · 2023: 35 · 2022: 30 · 2021: 34 · 2020: 45 · 2019: 36 · 2018: 33 · 2017: 32 · 2016: 31 · 2015: 35 · 2014: 45 · 2013: 31 · 2012: 17
FWCI: 15.15
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Thorax (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (publishedVersion)
HighWire Press Open Archive (submittedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords: chronic obstructive pulmonary disease, medication adherence, inhalation therapy, salmeterol, fluticasone propionate, all-cause mortality, hospitalization, COPD exacerbations, TORCH trial
MeSH terms: Fluticasone, Salmeterol Xinafoate, Administration, Inhalation, Adult, Aged, Aged, 80 and over, Albuterol, Androstadienes, Bronchodilator Agents, Drug Administration Schedule, Drug Combinations, Drug Therapy, Combination, Epidemiologic Methods, Female, Hospitalization, Humans, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adherence to inhaled therapy, mortality and hospital admission in COPD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks